Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000471287 | SCV000546546 | pathogenic | Beckwith-Wiedemann syndrome | 2016-06-24 | criteria provided, single submitter | clinical testing | This sequence change inserts 14 nucleotides in exon 5 of the NSD1 mRNA (c.2316_2329dup14), causing a frameshift at codon 777. This creates a premature translational stop signal (p.Leu777Glnfs*19) and is expected to result in an absent or disrupted protein product. While this particular variant has not been reported in the literature, truncating variants in NSD1 are known to be pathogenic (PMID: 12807965, 15942875, 17565729). For these reasons, this variant has been classified as Pathogenic. |
Labcorp Genetics |
RCV003231620 | SCV001588416 | pathogenic | Sotos syndrome | 2016-06-24 | criteria provided, single submitter | clinical testing | This sequence change inserts 14 nucleotides in exon 5 of the NSD1 mRNA (c.2316_2329dup14), causing a frameshift at codon 777. This creates a premature translational stop signal (p.Leu777Glnfs*19) and is expected to result in an absent or disrupted protein product. While this particular variant has not been reported in the literature, truncating variants in NSD1 are known to be pathogenic (PMID: 12807965, 15942875, 17565729). For these reasons, this variant has been classified as Pathogenic. |